SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,941,746 | -84.2% | 1,307,340 | -72.0% | 0.00% | -100.0% |
| Q2 2023 | $31,254,014 | -52.8% | 4,664,778 | -54.2% | 0.00% | 0.0% |
| Q1 2023 | $66,249,052 | +44.6% | 10,176,506 | +89.5% | 0.00% | -40.0% |
| Q4 2022 | $45,800,659 | +82.1% | 5,369,362 | +12.7% | 0.01% | +66.7% |
| Q3 2022 | $25,152,000 | +59.5% | 4,763,549 | +28.1% | 0.00% | +50.0% |
| Q2 2022 | $15,766,000 | +18.4% | 3,718,452 | -2.0% | 0.00% | +100.0% |
| Q1 2022 | $13,314,000 | -46.7% | 3,793,172 | +1.1% | 0.00% | -50.0% |
| Q4 2021 | $25,000,000 | -41.6% | 3,753,737 | -12.5% | 0.00% | -33.3% |
| Q3 2021 | $42,800,000 | -70.4% | 4,288,549 | -8.5% | 0.00% | -72.7% |
| Q2 2021 | $144,811,000 | -30.7% | 4,687,968 | -2.9% | 0.01% | -38.9% |
| Q1 2021 | $208,816,000 | +34.0% | 4,825,559 | +40.2% | 0.02% | +28.6% |
| Q4 2020 | $155,810,000 | – | 3,441,304 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |